A newly established muscular dystrophy research center in Seattle hopes to bring promising laboratory results into therapeutic trials.
The UW's teaching program for bioethics is recognized as one of the nation's most vibrant and comprehensive such collection of courses. UW Medicine writer Brian Donohue spoke with several instructors to generate a seven-part series of Q&As.
The hepatitis C virus has a previously unrecognized tactic to outwit antiviral responses and sustain a long-term infection.
Preclinical studies show that gene therapy can improve muscle strength in small- and large-animal models of a fatal congenital childhood dis
This story is the first in a series of seven articles about bioethics.
Within months, clinical trials of a gene therapy will begin with a small group of children affected with a deadly muscle-wasting disease.
